High UTX expression is associated with tamoxifen resistance in luminal A breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Dong-Hoon | - |
dc.contributor.author | Min, Kyueng-Whan | - |
dc.contributor.author | Chae, Seoung Wan | - |
dc.contributor.author | Do, Sung-Im | - |
dc.contributor.author | Oh, Young-Ha | - |
dc.contributor.author | Son, Byoung Kwan | - |
dc.date.accessioned | 2021-09-27T06:18:54Z | - |
dc.date.available | 2021-09-27T06:18:54Z | - |
dc.date.created | 2021-09-24 | - |
dc.date.issued | 2019-03 | - |
dc.identifier.issn | 0893-3952 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/133111 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | High UTX expression is associated with tamoxifen resistance in luminal A breast cancer | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Min, Kyueng-Whan | - |
dc.contributor.affiliatedAuthor | Oh, Young-Ha | - |
dc.identifier.wosid | 000478915500182 | - |
dc.identifier.bibliographicCitation | 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity | - |
dc.relation.isPartOf | 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity | - |
dc.relation.isPartOf | MODERN PATHOLOGY | - |
dc.citation.title | 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity | - |
dc.citation.conferencePlace | US | - |
dc.citation.conferencePlace | National Harbor, MD | - |
dc.citation.conferenceDate | 2019-03-16 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.